New vaccine protects children against six diseases

PARIS (Reuters) — The U.S. Food and Drug Administration approved Sanofi’s new pediatric vaccine immunizing children against six diseases, the French pharmaceutical lab said on Wednesday.

Sanofi developed the new vaccine, dubbed Vaxelis, in partnership with Merck.
Intended for pre-schoolers up to age 4, it protects against a range of common diseases: diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B, and invasive disease due to haemophilus influenza type B. Many schools require vaccinations before they will admit kids into their schools.